[HTML][HTML] Chemokines and chemokine receptors during COVID-19 infection

BA Khalil, NM Elemam, AA Maghazachi - Computational and structural …, 2021 - Elsevier
Chemokines are crucial inflammatory mediators needed during an immune response to
clear pathogens. However, their excessive release is the main cause of hyperinflammation …

[HTML][HTML] Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects

G Lisco, A De Tullio, E Jirillo, VA Giagulli… - Journal of …, 2021 - Springer
Background Thyroid dysfunction has been observed in patients with COVID-19, and
endocrinologists are requested to understand this clinical issue. Pandemic-related …

[HTML][HTML] Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection

RJ Farr, CL Rootes, LC Rowntree, THO Nguyen… - PLoS …, 2021 - journals.plos.org
The host response to SARS-CoV-2 infection provide insights into both viral pathogenesis
and patient management. The host-encoded microRNA (miRNA) response to SARS-CoV-2 …

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Future Medicine
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

Therapeutic monoclonal antibodies for COVID-19 management: an update

VP Chavda, R Prajapati, D Lathigara… - Expert opinion on …, 2022 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
affected more than 529 million people, and today the world is facing different mutant strains …

Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis

MM Eltobgy, A Zani, AD Kenney… - Proceedings of the …, 2022 - National Acad Sciences
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) is a worldwide health
concern, and new treatment strategies are needed. Targeting inflammatory innate immunity …

Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis

F Schweitzer, NN Kleineberg, Y Göreci… - Current opinion in …, 2021 - journals.lww.com
Neuro-COVID-19 is more than anosmia: clinical presentation,... : Current Opinion in
Neurology Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics …

[HTML][HTML] Immunosuppressant therapies in COVID-19: is the TNF axis an alternative?

Y Palacios, L Chavez-Galan - Pharmaceuticals, 2022 - mdpi.com
The study of cytokine storm in COVID-19 has been having different edges in accordance
with the knowledge of the disease. Various cytokines have been the focus, especially to …

[HTML][HTML] Implications of SARS-CoV-2 infection in systemic juvenile idiopathic arthritis

LM Ailioaie, C Ailioaie, G Litscher - International Journal of Molecular …, 2022 - mdpi.com
Systemic juvenile idiopathic arthritis (sJIA) is a serious multifactorial autoinflammatory
disease with a significant mortality rate due to macrophage activation syndrome (MAS) …

Cytokine storm associated with severe COVID‐19 infections: The potential mitigating role of omega‐3 fatty acid triglycerides in the ICU

DF Driscoll, BR Bistrian - The FASEB Journal, 2023 - Wiley Online Library
Cytokine storm during severe COVID‐19 infection increases the risk of mortality in critically
ill patients in the intensive care unit. Multiple therapeutic proposals include, for example, anti …